NCT00419055View on ClinicalTrials.gov

Outpatient Percutaneous Coronary Intervention

TerminatedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

August 31, 2004

Study Completion Date

August 31, 2006

Conditions
Coronary Artery Disease
Interventions
PROCEDURE

Early discharge after percutaneous coronary intervenntion

Eligible patients receive Bivalirudin at the standard dose during PCI and all have to be eligible for femoral access seal.

Sponsors
All Listed Sponsors
collaborator

Abbott Medical Devices

INDUSTRY

collaborator

The Medicines Company

INDUSTRY

lead

University of Pennsylvania

OTHER